openPR Logo
Press release

Non-insulin Therapies for Diabetes Market Size is Expected to Rise at a CAGR of 5.8% by 2034: TMR Research

07-16-2024 02:53 PM CET | Health & Medicine

Press release from: Transparency Market Research

Non-insulin Therapies for Diabetes

Non-insulin Therapies for Diabetes

Diabetes mellitus is a chronic condition characterized by elevated blood glucose levels due to the body's inability to produce or effectively use insulin. While insulin therapy has been a cornerstone in diabetes management, there is a growing demand for non-insulin therapies that offer effective glucose control with fewer side effects and improved patient compliance. The global market for non-insulin therapies for diabetes is expanding, driven by advancements in drug development, increasing prevalence of diabetes, and a shift towards personalized medicine. This article explores the current state and future prospects of the non-insulin therapies market.

Non-insulin Therapies for Diabetes Market (당뇨병 시장을 위한 비인슐린 치료법) is expected to grow at a CAGR of 5.8% from 2024 to 2034 and reach US$ 58.6 Bn by the end of 2034

Download Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86328

Overview of Non-insulin Therapies for Diabetes Market
The global non-insulin therapies market is witnessing significant growth, driven by the rising prevalence of diabetes, technological advancements in drug development, and increasing patient preference for non-invasive treatments. The market is segmented by drug class (GLP-1 receptor agonists, DPP-4 inhibitors, SGLT-2 inhibitors, alpha-glucosidase inhibitors, amylin analogs, and others), route of administration (oral, injectable), end-users (hospitals, clinics, home care settings), and geographical regions.

Top Companies:

GSK plc
Eli Lilly and Company
Sumitomo Pharma
Intarcia Therapeutics
Servier Laboratories
Pfizer Inc.
Merck & Co., Inc.
Dong-A Pharmaceutical Co., Ltd.
Luye Pharma Group
Eurofarma Laboratories SA

Recent Developments in Non-insulin Therapies Market
Recent advancements and trends in the non-insulin therapies market include:

Innovative Drug Classes: Development of novel drug classes such as GLP-1 receptor agonists, DPP-4 inhibitors, and SGLT-2 inhibitors that offer improved glycemic control and additional benefits like weight loss and cardiovascular protection.
Fixed-dose Combinations: Introduction of fixed-dose combination therapies that combine multiple mechanisms of action in a single pill, simplifying treatment regimens and improving adherence.
Extended-release Formulations: Development of extended-release formulations that reduce dosing frequency, enhance patient compliance, and provide more consistent glycemic control.
Digital Health Integration: Integration of digital health technologies, such as mobile apps and wearable devices, to monitor glucose levels, track medication adherence, and provide personalized feedback.
Biosimilars and Generics: Increasing availability of biosimilars and generic versions of non-insulin therapies, making these treatments more affordable and accessible.

Drivers of Market Growth
Several factors contribute to the growth of the non-insulin therapies market:

Rising Diabetes Prevalence: Increasing global prevalence of diabetes, driven by aging populations, rising obesity rates, and sedentary lifestyles, necessitates effective management options.
Patient Preference: Growing patient preference for non-insulin therapies due to their non-invasive nature, fewer side effects, and additional health benefits.
Technological Advancements: Continuous advancements in drug development technologies, leading to the creation of more effective and safer non-insulin therapies.
Healthcare Policies: Favorable healthcare policies and government initiatives aimed at improving diabetes management and patient outcomes.
Focus on Personalized Medicine: Increasing focus on personalized medicine, which tailors treatment plans based on individual patient profiles, enhancing the efficacy of non-insulin therapies.

Explore Sample of the Report:
https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=86328

Market Segmentation:

Drug Class
Biguanides
Sulfonylureas
Thiazolidinediones
Alpha-Glucosidase Inhibitors
DPP-4 Inhibitors
GLP-1 Analogs
Sodium-glucose co-transporter-2 (SGLT2) Inhibitors

Route of Administration
Oral
Intramuscular

End-user
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

By Region
North America
Europe
Asia Pacific
Latin America
Middle East & Africa

Buy this Premium Research Report:
https://www.transparencymarketresearch.com/checkout.php?rep_id=86328<ype=S

More Trending Report by Transparency Market Research:

Pharmaceutical Chemicals Market (医薬品化学品市場): https://www.globenewswire.com/en/news-release/2024/01/15/2808957/32656/en/Pharmaceutical-Chemicals-Market-Size-to-be-Worth-USD-339-3-billion-by-2031-with-a-Projected-CAGR-of-5-8-Says-Transparency-Market-Research-Inc.html

OPGW Cable Market (Marché des câbles OPGW): https://www.globenewswire.com/news-release/2024/02/28/2837197/32656/en/OPGW-Cable-Market-Expected-to-Reach-USD-876-8-million-by-2031-Growing-at-a-CAGR-of-4-8-Transparency-Market-Research-Inc.html

About Transparency Market Research

Transparency Market Research, a global market research company registered at Wilmington, Delaware, United States, provides custom research and consulting services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insights for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants use proprietary data sources and various tools & techniques to gather and analyses information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

𝐂𝐨𝐧𝐭𝐚𝐜𝐭 𝐔𝐬
Transparency Market Research Inc.
CORPORATE HEADQUARTER DOWNTOWN,
1000 N. West Street,
Suite 1200, Wilmington, Delaware 19801 USA
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Non-insulin Therapies for Diabetes Market Size is Expected to Rise at a CAGR of 5.8% by 2034: TMR Research here

News-ID: 3584029 • Views:

More Releases from Transparency Market Research

Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 - Transparency Market Research
Global Solar Powered Agricultural Dryer Market to Exceed USD 2.4 Billion by 2031 …
The global solar powered agricultural dryer market, valued at US$ 1.6 billion in 2022, is projected to grow at a CAGR of 5.8% from 2023 to 2031, reaching US$ 2.4 billion by the end of 2031. Rising investments in renewable energy, growing awareness of sustainable agricultural practices, and the rapid expansion of the agricultural sector driven by population growth are key factors fueling market growth. Uncover essential discoveries and trends from
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Radiopharmaceuticals to Propel Market Expansion | Transparency Market Research, Inc
Technetium-99m Market Forecast 2034: Rising Demand for Diagnostic Imaging and Ra …
The global Technetium‐99m Market was valued at US$ 6.0 Billion in 2023 and is projected to grow at a CAGR of 3.3% from 2024 to 2034, surpassing US$ 8.6 Billion by the end of the forecast period. Advancements in nuclear imaging infrastructure, government-backed healthcare initiatives, and an increasing demand for precise diagnostic procedures are fueling this growth. Discover essential conclusions and data from our Report in this sample - https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=77100 Analysts' Viewpoint The Technetium‐99m
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to US$ 280 Million by 2030, Driven by Rising Equine Diseases and Diagnostic Advancements
Equine Diagnostic Services Market Outlook 2030: From US$ 168 Million in 2019 to …
The global Equine Diagnostic Services Market, valued at approximately US$ 168 million in 2019, is projected to expand at a compound annual growth rate (CAGR) of ~5% from 2020 to 2030, reaching around US$ 280 million by 2030. Equine diagnostic services, encompassing tests like genetic, infectious disease, and imaging diagnostics, are critical for managing horse health in veterinary hospitals, clinics, and mobile settings. The market is driven by increasing equine
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of 6.1%
Digital Printing Market to Reach USD 54.4 Billion by 2034, Growing at a CAGR of …
The digital printing market is experiencing strong growth, driven by rapid technological advancements, rising demand for personalized and on-demand printing, and an increasing focus on sustainable solutions. Digital printing allows for the direct transfer of digital files onto a wide range of substrates, offering high-resolution output with greater speed and flexibility. Its adaptability has led to broad adoption across industries such as packaging, textiles, publishing, and advertising-sectors where customization, efficiency,

All 5 Releases


More Releases for Diabetes

Major Force in the Diabetes Pen Market 2025: Diabetes Fuels Surge In Demand For …
How Will the Diabetes Pen Market Grow, and What Is the Projected Market Size? The diabetes pen market is projected to grow from $29.24 billion in 2024 to $31.22 billion in 2025, at a CAGR of 6.8%. Growth is fueled by the rising need for managing diabetes, advancements in diabetes care, and an increasing focus on patient-friendly medication administration tools. The diabetes pen market is projected to grow strongly, reaching $40.17 billion
Diabetes Monitoring Devices Market: Regaining Its Glory| Ascensia Diabetes Care, …
The Latest Study Published by HTF MI Research on the "Diabetes Monitoring Devices Market'' evaluates market size, trend and forecast to 2029. The Diabetes Monitoring Devices market study includes significant research data and evidences to be a practical resource document for managers and analysts is, industry experts and other key people to have an easily accessible and self-analysed study to help understand market trends, growth drivers, opportunities and upcoming challenges
Prevalence of Diabetes Drives Opportunities for Type-2 Diabetes Market
The Type-2 Diabetes Market Analysis, 2023, by MarkNtel Advisors, presents a well-researched, detail-driven, and accurate study for the stakeholders. This analysis entails prominent aspects like trends, & recent developments, drivers, opportunities, challenges, & restraints, among other parameters, influencing the overall industry expansion across different locations. This report comprises data from historic years (2018-21) & the base year (2022) to put together an estimation of the forecast period (2023-28). According to Type-2 Diabetes Market
Reverse Diabetes with Dr. Merritt’s Diabetes Reversal Recipe
[November 26, 2020] – People suffering from diabetes always search for ways to lower blood sugar levels in their bodies. Diabetes treatment available costs you hundreds of dollars yearly and also restricts you to a diabetic diet. That hampers your mental health and well-being. Apart from this, eye problems, kidney failure, amputations are some of the physical problems diabetic patients face. Dr. Marlene Merritt (from the Merritt Wellness Center in
Emerging trends for Diabetes Care Devices Market 2020 astonishing growth by Worl …
The global diabetes care devices market is expected to reach US$ 39,382.3 Mn in 2027 from US$ 23,354.3 Mn in 2018. The market is estimated to grow with a CAGR of 6.1% from 2020-2027. Premium market insights recently published a report titled "Diabetes Care Devices Market Size and Forecast to 2026". The report includes an authentic and accurate research study into the global Diabetes Care Devices market based on a qualitative
Diabetes Treatment
Diabetes Treatment is a important way to help manage the healthy ,easy to use and improve the way of the treatment of blood glucose monitoring system. As living standards improve, an increasing obesity, the Diabetes Treatment has improved peoples living habits, disease control effect, is becoming more and more important. The global Diabetes Treatment market is valued at 43700 million US$ in 2018 and will reach 58000 million US$ by the end